Amgen (NASDAQ:AMGN) Price Target Cut to $310.00 by Analysts at Piper Sandler
By MarketBeat News | Published on 2025-01-03T07:51:40Z
Description
Amgen (NASDAQ:AMGN – Free Report) had its price objective lowered by Piper Sandler from $344.00 to $310.00 in a research report report published on Thursday,Benzinga reports. The firm currently has an overweight rating on the medical research company's stock.…
Full Content
Amgen (NASDAQ:AMGN – Free Report) had its price objective lowered by Piper Sandler from $344.00 to $310.00 in a research report report published on Thursday,Benzinga reports. The firm currently has a… [+5722 chars]
Insights
This article highlights recent developments in the world of news. Stay informed with the latest updates on global events, technology, politics, entertainment, and more. Dive into the details to get a comprehensive understanding of this topic.
Comments
Post a Comment